It was found that CIDP patients with NF155 antibodies had higher levels of CSF protein and of IL-13, IL-8, C–C motif chemokine 11 (CCL11), MCP-1, TNF-α, and IFN-γ compared to non-inflammatory neurological disease patients. This evidence concerns the gene CCL2 and chronic inflammatory demyelinating polyradiculoneuropathy.